ATLASKura Oncology (KURA) earnings date: Nov 3, 2026
Kura Oncology (KURA) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of -$0.83.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KURA
| Last price | $9.79 (-4.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.2% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Kura Oncology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Kura Oncology reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Kura Oncology. You can switch it off at any time.
Alert me before KURA reportsFree to start. Creating an account takes under a minute.
Notify me when Kura Oncology reports
Track KURA free Add Kura Oncology to a free ATLAS watchlist and see its next report date in one place.
KURA earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.83 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -39.7% |
| Average move around a report | ±3.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Kura Oncology earnings history: last 5 reports
Kura Oncology last reported on Aug 12, 2026: EPS of -$0.77 against an estimate of -$0.88 (+12.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.88 | -$0.77 | +12.5% | Beat | +1.6% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +0.9% |
| Mar 5, 2026 | -$0.49 | -$0.92 | -87.8% | Miss | +4.8% |
| Nov 4, 2025 | -$0.68 | -$0.85 | -25.0% | Miss | +1.7% |
| Aug 7, 2025 | -$0.37 | -$0.75 | -102.7% | Miss | -8.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KURA
See the fair value, the probability range and the earnings history of Kura Oncology on its ATLAS page.
Kura Oncology (KURA) stock analysisPlans from €3.99 a month.
Kura Oncology earnings: frequently asked questions
When does Kura Oncology (KURA) report earnings?
Kura Oncology is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for KURA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.83 per share (USD). Estimates can change before the report.
How often does KURA beat earnings estimates?
Of its last 5 reports with a recorded result, Kura Oncology beat the EPS estimate 2 times; the average surprise was -39.7%. Past results do not predict the next one.
How much does KURA move around earnings?
Over its last 5 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Kura Oncology beat earnings estimates last quarter?
Kura Oncology last reported on Aug 12, 2026: EPS of -$0.77 against an estimate of -$0.88 (+12.5% surprise), a beat.
How much does KURA usually move in a day?
On a normal trading day the ATLAS model puts KURA’s one-day range at about ±3.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer